← Eichor
Study identifier: NCT02691858 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

Condition: Intussusception  ·  Sponsor: Cairo University

PhaseNA
Planned participants80
Who can joinAll sexes, 3 Months to 4 Years
Healthy volunteersNo

About this study

Intussusception is one of the most frequent causes of acute bowel and second most common cause of acute abdominal pain in pediatric age .95 % of cases are idiopathic, the rest are either due to pathological lead point or post operative. Treatment of intussusception must start with medical resuscitation, then radiological or operative reduction of intussusception. Our surgery team has used hydrocortisone with the medical resuscitation to improve the success rate of pneumatic reduction and decrease the number of reduction trials.

This description comes directly from the study's public registry record.

Talk to the study team

Mostafa Gad, MSc  ·  201002265009  ·  mostafagad@kasralainy.edu.eg

Mahmoud Elfiky, MD  ·  201001557755  ·  mfiky@kasralainy.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo University Pediatric HospitalCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02691858